THE INTERPLAY BETWEEN C-MYCONCOGENE EXPRESSION AND CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR, ITS ANTAGONIST RECEPTOR, FUNS-LIKE TYROSINE KINASE 1 IN DIFFUSE LARGE B CELL LY - Egyptian Knowledge Bank

373099

THE INTERPLAY BETWEEN C-MYCONCOGENE EXPRESSION AND CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR, ITS ANTAGONIST RECEPTOR, FUNS-LIKE TYROSINE KINASE 1 IN DIFFUSE LARGE B CELL LY

Article

Last updated: 29 Dec 2024

Overview Similar Items

Article

THE STUDY OFLONG NON-CODING RNAs(NAALADL2 AND XIST) GENEEXPRESSION IN DIFFUSE LARGE B CELL LYMPHOMA

Article

Vascular endothelial growth factor & basic fibroblast growth factor polymorphism as prognostic factors in Non-Hodgkin Lymphoma

Article

Role of Proangiogenic Tyrosine Kinase with Immunoglobulin and Endothelial Growth Factor Homology Domains 2 Expressing Monocytes in Chronic Lymphocytic Leukemia

Article

Inverse correlation of concurrent BCL2, and C MYC expressions and CD30 ‎positivity as regard the Prognostic significance in diffuse large B-cell ‎lymphoma

Article

Relationship between C-MYC, BCL-2 and BCL-6 Genetic Abnormalities and Bone Marrow Biopsy in B-Non-Hodgkin Lymphoma

Article

Study of high mobility group box 1 protein level in patients with diffuse large b cell lymphoma

Article

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

Article

Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

Article

The Role of Cell-Free DNA as a Prognostic Marker in Diffuse Large B Cell Lymphoma with Hepatitis C

Article

THE TUMOR SUPPRESSOR NDRG2 DISRUPTS THE ONCOGENICITY OF THE CYTOPLASMIC PRMT5 IN ATL LEUKEMIA